Bristol-Myers Squibb withdraws NDA

BMY withdrew the NDA for its UFT tegafur uracil capsules for use with leucovorin calcium tablets in the first-line treatment of advanced colorectal cancer. On Sept. 16, 1999, the FDA's Oncologic Drugs...